BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Akel H, Ismail R, Katona G, Sabir F, Ambrus R, Csóka I. A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. Int J Pharm 2021;604:120724. [PMID: 34023443 DOI: 10.1016/j.ijpharm.2021.120724] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Khan MS, Mohapatra S, Gupta V, Ali A, Naseef PP, Kurunian MS, Alshadidi AAF, Alam MS, Mirza MA, Iqbal Z. Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier. Membranes 2023;13:343. [DOI: 10.3390/membranes13030343] [Reference Citation Analysis]
2 Marcello E, Chiono V. Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting. Int J Mol Sci 2023;24. [PMID: 36834804 DOI: 10.3390/ijms24043390] [Reference Citation Analysis]
3 Arooj A, Rehman AU, Iqbal M, Naz I, Alhodaib A, Ahmed N. Development of Adapalene Loaded Liposome Based Gel for Acne. Gels 2023;9. [PMID: 36826305 DOI: 10.3390/gels9020135] [Reference Citation Analysis]
4 Aziz T, Nadeem AA, Sarwar A, Perveen I, Hussain N, Khan AA, Daudzai Z, Cui H, Lin L. Particle Nanoarchitectonics for Nanomedicine and Nanotherapeutic Drugs with Special Emphasis on Nasal Drugs and Aging. Biomedicines 2023;11. [PMID: 36830891 DOI: 10.3390/biomedicines11020354] [Reference Citation Analysis]
5 Djekic L. Novel Mucoadhesive Polymers for Nasal Drug Delivery. Nasal Drug Delivery 2023. [DOI: 10.1007/978-3-031-23112-4_11] [Reference Citation Analysis]
6 Dhas N, Neyyar S, Garkal A, Kudarha R, Patel J, Mutalik S, Mehta T. Biomedical Applications of Nanocarriers in Nasal Delivery. Nasal Drug Delivery 2023. [DOI: 10.1007/978-3-031-23112-4_7] [Reference Citation Analysis]
7 Li L, He R, Yan H, Leng Z, Zhu S, Gu Z. Nanotechnology for the diagnosis and treatment of Alzheimer's disease: A bibliometric analysis. Nano Today 2022;47:101654. [DOI: 10.1016/j.nantod.2022.101654] [Reference Citation Analysis]
8 Adalbert L, Kanti SPY, Jójárt-Laczkovich O, Akel H, Csóka I. Expanding Quality by Design Principles to Support 3D Printed Medical Device Development Following the Renewed Regulatory Framework in Europe. Biomedicines 2022;10. [PMID: 36428514 DOI: 10.3390/biomedicines10112947] [Reference Citation Analysis]
9 Mardikasari SA, Sipos B, Csóka I, Katona G. Nasal route for antibiotics delivery: Advances, challenges and future opportunities applying the quality by design concepts. Journal of Drug Delivery Science and Technology 2022;77:103887. [DOI: 10.1016/j.jddst.2022.103887] [Reference Citation Analysis]
10 Esim O, Oztuna A, Sarper M, Hascicek C. Chitosan-coated bovine serum albumin nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. Journal of Drug Delivery Science and Technology 2022;77:103906. [DOI: 10.1016/j.jddst.2022.103906] [Reference Citation Analysis]
11 Nižić Nodilo L, Perkušić M, Ugrina I, Špoljarić D, Jakobušić Brala C, Amidžić Klarić D, Lovrić J, Saršon V, Safundžić Kučuk M, Zadravec D, Kalogjera L, Pepić I, Hafner A. In situ gelling nanosuspension as an advanced platform for fluticasone propionate nasal delivery. Eur J Pharm Biopharm 2022:S0939-6411(22)00081-9. [PMID: 35489667 DOI: 10.1016/j.ejpb.2022.04.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Akel H, Katona G, Csóka I. In vitro quantitative comparison study of insulin SLNs and PLGA NPs as potential carriers for the brain delivery of intranasal insulin. IV. Symposium of Young Researchers on Pharmaceutical Technology, Biotechnology and Regulatory Science 2022. [DOI: 10.14232/syrptbrs.2022.24] [Reference Citation Analysis]
13 Akel H, Csóka I, Ambrus R, Bocsik A, Gróf I, Mészáros M, Szecskó A, Kozma G, Veszelka S, Deli MA, Kónya Z, Katona G. In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin. Int J Mol Sci 2021;22:13258. [PMID: 34948054 DOI: 10.3390/ijms222413258] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
14 Mukhtar M, Szakonyi Z, Farkas Á, Burian K, Kókai D, Ambrus R. Freeze-dried vs spray-dried nanoplex DPIs based on chitosan and its derivatives conjugated with hyaluronic acid for tuberculosis: In vitro aerodynamic and in silico deposition profiles. European Polymer Journal 2021;160:110775. [DOI: 10.1016/j.eurpolymj.2021.110775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Németh Z, Pallagi E, Dobó DG, Kozma G, Kónya Z, Csóka I. An Updated Risk Assessment as Part of the QbD-Based Liposome Design and Development. Pharmaceutics 2021;13:1071. [PMID: 34371762 DOI: 10.3390/pharmaceutics13071071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]